Patent application number | Description | Published |
20130138222 | Osteoconductive Implants and Methods of Using Same - Implants for promoting bone growth and methods of using same, the implants including a perforated placental membrane sheet wrapped around an osteoconductive material composed of bone chips, bone granules, bone powders or combinations thereof, the osteoconductive material being configured for providing a scaffold upon which bone growth can occur. The placental membrane sheet acts to maintain the osteoconductive material in a cohesive, organized configuration within a site of a patient where bone growth is to be induced. The perforations in the placental membrane sheet create passageways in the exterior of the implant through which the osteoconductive material can communicate with adjacent bone surfaces which are to be fused. | 05-30-2013 |
20130144386 | Osteoconductive Implants and Methods of Using Same - Implants for promoting bone growth and methods of using same, the implants including a perforated placental membrane sheet wrapped around an osteoconductive material composed of bone chips, bone granules, bone powders or combinations thereof, the osteoconductive material being configured for providing a scaffold upon which bone growth can occur. The placental membrane sheet acts to maintain the osteoconductive material in a cohesive, organized configuration within a site of a patient where bone growth is to be induced. The perforations in the placental membrane sheet create passageways in the exterior of the implant through which the osteoconductive material can communicate with adjacent bone surfaces which are to be fused. | 06-06-2013 |
20140271776 | Preparations Derived From Placental Materials and Methods of Making and Using Same - Preparations derived from placental materials and methods of making and using same, the preparations including a first preparation composed of placental membranes digested in collagenase, a second preparation composed of multipotent cells derived from the collagenase digested placental membranes and that are grown in adherent culture beyond confluence and a third preparation composed of ground placental membranes re-suspended in a fluid containing hyaluronic acid. The preparations can be used for regenerating damaged or defective tissue including connective tissue, nerve tissue, muscle tissue, skin tissue, cartilage tissue and bone tissue. The preparations can also be used as dermal fillers in cosmetic and plastic surgery applications. | 09-18-2014 |
20140274899 | Preparations Containing Hepatocyte Growth Factor and Hyaluronic Acid and Methods of Making and Using Same - Preparations containing hepatocyte growth factor (HGF) and hyaluronic acid (HA) and methods of making and using same. The HGF and HA preparations can be prepared together in solution as an injectable fluid without gelatinization, or impregnated within a porous hydrophilic matrix material with, or without, cross-linking of the HA with the matrix material. The preparations can be used as a dermal filler or to generate and promote healing of cartilage, vertebral discs, connective tissues such as tendons and ligaments and bone in vivo. | 09-18-2014 |
20140277165 | Sacroiliac Joint Stabilization Method - A method for treating back pain by stabilizing the sacroiliac joint. The method includes fusing a sacrum bone to an ilium bone or otherwise mechanically immobilizing the sacroiliac joint by inserting at least two implants into voids formed within or between the articular surfaces of each sacroiliac joint of a patient without substantially distracting the joint. The voids are arranged within each joint at either a converging orientation or a diverging orientation. A kit containing the implants and tools required to insert the implants into the joint are also described. | 09-18-2014 |
20140277502 | Anterior Lumbar Fusion Method and Device - A method and devices for placing spinal implants including placing the implants completely within a spaced defined between adjacent vertebral bodies where the implants are supported by the cortical bone of the vertebral bodies. An insertion instrument places the implants in pairs with a variable-sized space placed in between. The implants are made of a biocompatible material and are particularly suited for anterior lumbar interbody fusion surgery. The spinal implants used to facilitate spinal fusion, correct deformities, stabilize and strengthen the spine. | 09-18-2014 |
20150216910 | Expandable Amnion Membrane for Treating Non-Healing Wounds - The present disclosure generally pertains to methods of treating non-healing wounds. Specifically, the method includes injecting amnion fluid derived cells along the periphery of the wound. The wound is then treated with a placental membrane material including a plurality of slits for increasing the membranes capacity to expand. The slits produce a mesh-like pattern in the membrane material. The amniotic derived cells deliver to the wound electrolytes, growth factors, carbohydrates, lipids, proteins, amino acids, lactate, pyruvate, enzymes, hormones and other factors useful in wound repair. The membrane material provides a scaffolding structure supporting cell growth, prevents microbial infection and decreases the rate of passive evaporative water and heat loss. The combination of the amniotic derived cells and the membrane material protects the wound and promotes cell regeneration. | 08-06-2015 |
20150216911 | Multipotent Prenatal Stem Cells - The present invention relates to the isolation, propagation and use of prenatal stem cells. The cells are CD105 negative. In certain embodiments the cells are also SSEA-4 positive or negative, and c-kit negative. The cells may be isolated from a prenatal sample, for instance third trimester amniotic fluid or placental membrane. The cells may be combined with a biologically compatible solution or a biologically compatible matrix and utilized to treat a human subject. The invention also contemplated enriched populations of prenatal stem cells. The enriched cell population may be propagated in the appropriate culture medium and the resulting progeny cells utilized therapeutic applications. | 08-06-2015 |